Acute myocarditis associated with COVID-19 infection

Beşler, Muhammed Said; Arslan, Halil

doi:10.1016/j.ajem.2020.05.100

Cited by 57 publications

(53 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…pneumonia. Early reports have indicated that fulminant myocarditis may occur in SARS-CoV-2 infection, contributing significantly to morbidity of COVID-19 [ [29] , [30] , [31] , [32] , [33] , [34] ]. In addition, acute lymphocytic myocarditis has been demonstrated in endomyocardial biopsies of patients with clinically suspected SARS-CoV-2 associated myocarditis [ 35 , 36 ].…”

Section: Discussionmentioning

confidence: 99%

Analysis of cardiopulmonary findings in COVID-19 fatalities: High incidence of pulmonary artery thrombi and acute suppurative bronchopneumonia

Grosse

Salzer

et al. 2020

Cardiovascular Pathology

114

125

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Analysis of cardiopulmonary findings in COVID-19 fatalities: High incidence of pulmonary artery thrombi and acute suppurative bronchopneumonia

Grosse

Salzer

et al. 2020

Cardiovascular Pathology

114

125

View full text Add to dashboard Cite

show abstract

“…Those with a severe and depressed LV function developed cardiogenic shock, thereby having a worse prognosis 4,6 . Although CMR was not performed in all cases because of prolonged acquisition time and the fact that COVID-19 infection is highly contagious, it showed myocardial edema and sub-epicardial late gadolinium enhancement in some parts of the LV [7][8][9][10][11][12]16 . Interestingly, no EMB was performed to confirm the diagnosis in all patients even though it is considered a gold standard.…”

Section: Imaging Featuresmentioning

confidence: 99%

COVID-19 and acute myocarditis: current literature review and diagnostic challenges

Çınar

Hayıroğlu

Çiçek

et al. 2020

Rev. Assoc. Med. Bras.

View full text Add to dashboard Cite

SUMMARY INTRODUCTION In the current literature, there has been an upsurge of cases of COVID-19-induced acute myocarditis. In this case-based review, we aimed to describe the clinical characteristics, imaging findings, and in-hospital course of acute myocarditis. In addition, the limitations of the myocarditis diagnosis were discussed since only fulminant myocarditis cases have been mentioned in the current literature. METHODS We performed a review of the literature of all patients who were diagnosed with COVID-19-induced acute myocarditis using the databases of PubMed, Embase, and the Cochrane. RESULTS 16 case reports were found to be related to COVID-19-induced acute myocarditis. We observed that the ECG findings in most of the COVID-19 patients were non-specific, including diffuse ST-segment elevation, non-specific intraventricular conduction delay, sinus tachycardia, and inverted T-waves in anterior leads. Echocardiographic findings of COVID-19-induced acute myocarditis patients ranged from preserved left ventricular ejection fraction (LVEF) without segmental abnormalities to reduced LVEF with global hypokinesia. Interestingly, a few patients with COVID-19-induced acute fulminant myocarditis were steroid-responsive and had an amelioration with glucocorticoid and immunoglobulin therapy. CONCLUSION Despite the COVID-19 pandemic worldwide, a limited number of cases has been shared in the current literature. There are a lot of difficulties in the differential diagnosis of acute myocarditis in the context of COVID-19.

show abstract

“…21 Presenting symptoms are broad and nonspecific, including fatigue, chest discomfort, dyspnoea, heart failure as well as fulminant myocarditis with hemodynamic instability. [22][23][24][25][26][27][28][29][30][31][32][33] Patients are often found to have ST-T wave changes on electrocar- 7 The systemic inflammation and catecholamine surge caused by COVID-19 also increases plaque vulnerability and rupture. 7,35 In a case series conducted by Bangalore et al, 18 patients with COVID-19 with ST-segment elevation on electrocardiogram indicating potential acute myocardial infarction were studied.…”

Section: Acute Myocarditismentioning

confidence: 99%

Coronavirus disease‐19 and cardiovascular disease: A risk factor or a risk marker?

Liu

Virani

Alam

et al. 2020

Reviews in Medical Virology

View full text Add to dashboard Cite

Severe acute respiratory syndrome coronavirus-2 causes the clinical syndrome of coronavirus disease of 2019 (COVID-19) which has become a global pandemic resulting in significant morbidity and mortality. While the virus primarily affects the respiratory system, it also causes a wide variety of complex cardiac manifestations such as acute myopericarditis, acute coronary syndrome, congested heart failure, cardiogenic shock and cardiac arrhythmias. There are numerous proposed mechanisms of cardiac injury, including direct cellular injury, pro-inflammatory cytokine storm, myocardial oxygen-demand mismatch, and systemic inflammation causing multi-organ failure. Additionally, medications commonly used to treat COVID-19 patients have various cardiovascular side effects. We aim to provide a succinct review about the pathophysiology and cardiac manifestations of COVID-19, as well as treatment considerations and the various adaptations made to the current healthcare structure as a result of the pandemic.

show abstract

Acute myocarditis associated with COVID-19 infection

Cited by 57 publications

References 10 publications

Analysis of cardiopulmonary findings in COVID-19 fatalities: High incidence of pulmonary artery thrombi and acute suppurative bronchopneumonia

Analysis of cardiopulmonary findings in COVID-19 fatalities: High incidence of pulmonary artery thrombi and acute suppurative bronchopneumonia

COVID-19 and acute myocarditis: current literature review and diagnostic challenges

Coronavirus disease‐19 and cardiovascular disease: A risk factor or a risk marker?

Contact Info

Product

Resources

About